Aptevo Therapeutics, Inc. (APVO)
5.18
+0.44
(+9.28%)
USD |
NASDAQ |
Apr 14, 16:00
5.18
0.00 (0.00%)
After-Hours: 20:00
Aptevo Therapeutics EPS Diluted (Quarterly) : -5.911 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.806M |
| Total Expenses (Quarterly) | 5.806M |
| Enterprise Value | -12.26M |
| Earnings Yield | -34.34K% |
| Normalized Earnings Yield | -34344.72 |